The estimated Net Worth of Steven Frank is at least $1.26 Milione dollars as of 9 March 2024. Mr. Frank owns over 106,837 units of Precigen Inc stock worth over $959,519 and over the last 11 years he sold PGEN stock worth over $0. In addition, he makes $299,993 as Independent Director at Precigen Inc.
Steven has made over 12 trades of the Precigen Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently he exercised 106,837 units of PGEN stock worth $103,632 on 9 March 2024.
The largest trade he's ever made was buying 400,000 units of Precigen Inc stock on 14 August 2023 worth over $688,000. On average, Steven trades about 15,244 units every 48 days since 2013. As of 9 March 2024 he still owns at least 989,195 units of Precigen Inc stock.
You can see the complete history of Mr. Frank stock trades at the bottom of the page.
Steven R. Frank serves as Independent Director of the Company. Mr. Frank has served as a Board member since February 2008. Mr. Frank joined J.P. Morgan Securities LLC, an investment bank, in June 2008 and currently serves as Chairman of Global Healthcare Investment Banking. Mr. Frank had previously been the head of Bear Stearns’ Worldwide Health Care Investment Banking group in New York for 16 years and has provided general investment banking services to all types of health care companies. Specifically, Mr. Frank has led or played major roles in hundreds of mergers and acquisitions and financing transactions across the spectrum of deal structures. He has specialized in transactions involving pharmaceutical, medical device, and biotechnology companies. Prior to joining Bear Stearns in 1993, Mr. Frank served for over ten years as an institutional investor, primarily at State Farm Insurance Company, where he focused on a multi-billion dollar life-sciences portfolio. Mr. Frank holds a B.S. from Illinois State University and an M.B.A. from the University of Chicago.
As the Independent Director of Precigen Inc, the total compensation of Steven Frank at Precigen Inc is $299,993. There are 15 executives at Precigen Inc getting paid more, with Randal Kirk having the highest compensation of $2,067,620.
Steven Frank is 60, he's been the Independent Director of Precigen Inc since 2008. There are 8 older and 10 younger executives at Precigen Inc. The oldest executive at Precigen Inc is Robert Shapiro, 81, who is the Lead Independent Director.
Over the last 5 years, insiders at Precigen Inc have traded over $44,216,787 worth of Precigen Inc stock and bought 52,689,457 units worth $114,197,137 . The most active insiders traders include Randal J Kirk, Trading S.A. Ares e Helen Sabzevari. On average, Precigen Inc executives and independent directors trade stock every 9 days with the average trade being worth of $358,866. The most recent stock trade was executed by Randal J Kirk on 9 August 2024, trading 23,529,411 units of PGEN stock currently worth $19,999,999.
precigen, inc. discovers and develops the next generation of gene and cellular therapies in the united states. it also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; proprietary methane bioconversion platform that turns natural gas into energy and chemical products; and reproductive and embryo transfer technologies. in addition, the company offers ultravector platform that incorporates advanced dna construction technologies and computational models to design and assemble genetic components into complex gene expression programs; mbil15, a gene that enhances functional characteristics of immune cells; sleeping beauty, a non-viral transposon/transposase system; attsite recombinases, which breaks and rejoins dna at specific sequences; adenoverse technology platform, a library of engineered adenovector serotypes; and l. lactis is a food-grade bacterium. additionally, it provides rheoswitch inducible gene switch that provides qua
Precigen Inc executives and other stock owners filed with the SEC include: